四君子汤合丁香柿蒂汤治疗慢性胃炎的疗效分析

<正>1临床资料选取本院2010年5月~2012年5月收治的慢性胃炎[1]患者共100例,其中男性患者40例,女性患者60例;年龄为29~70岁,平均年龄为(55.0±2.0)岁;病程为3年20年,平均病程为(10.0±2.0)年。通过胃镜检查证实其为慢性胃炎。2治疗方法予四君子汤合丁香柿蒂汤治疗,组成:党参20g、白术10g、柿蒂6g、丁香6g、茯苓10g、生姜6g。每天1剂,水煎取汁,早晚     

腹膜后肿瘤35例临床分析

<正>腹膜后肿瘤有其独特的临床特点,其外科手术也有自身特点。我院手术治疗腹膜后肿瘤35例,疗效尚可,报道如下。1资料与方法1.1一般资料2002年4月—2011年4月我院收治腹膜后肿瘤患者35例,其中男12例,女23例;年龄23~67岁,平均年龄45岁。体检发现腹部包块12例,腰部疼痛13例,腹部不适10例。有高血压病史10例。所有病例术前均行腹部CT检查,3例合并右侧肾盂积水,11例合并结肠及小肠侵犯。     

更昔洛韦联合He-Ne激光治疗带状疱疹41例疗效观察

2008年12月~2010年6月,采用静滴更昔洛韦联合He-Ne激光局部照射治疗带状疱疹取得较好疗效,现报告如下:     

老年患者开胸手术后呼吸道的护理

开胸手术后呼吸道护理是防止肺部并发症的关键。由于开胸手术后患者的肺活量减少，残气量增加，最大通气量明显减少，氧利用系数降低，膈肌活动幅度减少，肺顺应性降低，所以极易发生呼吸道并发症。我科自2003年1月－2007年1月，对73例老年患者实施胸科手术，男50例，女23例，年龄60－84岁，平均年龄66岁。施行全肺切除术7例，肺叶切除术54例，胸膜纤维板剥脱术12例。术后根据患者呼吸系统的症状，进行了吸氧、呼吸道湿化，协助排痰，保持呼吸道通畅等积极有效的护理措施，取得了较好的效果，报道如下。     

重新评估β受体阻滞剂在高血压方面的疗效：荟萃分析

最近发表的1篇荟萃分析中，研究者认为β受体阻滞剂不应该用于治疗高血压（CMAJ，2006，174：1737—1742）。基于老年人和年青人高血压的发病机制不同，该荟萃分析旨在阐明不同年龄人群β受体阻滞剂的疗效。研究首要终点是：全因卒中、心肌梗死和死亡。方法：该文汇总随机对照试验，评价β受体阻滞剂治疗高血压一线用药预防主要心血管事件发生的疗效。中老年患者（平均年龄≥60岁）与年青患者（平均年龄〈60岁）分开分析，采用随机效应模式汇总数据，结果：汇总21项高血压试验中145811名患者的数据，发现在安慰剂-对照试验中，β受体阻滞剂可以降低年青患者主要心血管事件的发生率[危险比（RR）=0．86，     

11例矽肺合并自发性气胸的护理体会

矽肺是因长期吸入二氧化硅粉尘引起的,以肺部弥漫性纤维化为主的全身性疾病。由于矽肺间质广泛纤维组织增生,最后在纤维团块周围肺组织出现代偿性肺气肿甚至形成肺大泡,当剧烈咳嗽或过度用力时,肺大泡破裂形成自发性气胸。因此,防治并发症在矽肺治疗和护理中有很重要的意义。我院自2003年7月至2005年9月收治矽肺合并自发性气胸11例,均为男性,年龄32～63岁,平均年龄40岁,以工人居多,文化程度低,Ⅱ期矽肺6例,Ⅲ期矽肺5例,双侧气胸并皮下气肿2例,双侧气胸5例,合并肺结核4例。1一般护理心理护理:对患者作好解释工作,情感支持,使患者产生信任和亲…     

胆心综合征误诊为急性冠状动脉综合征13例临床分析

本文将通辽市科尔沁区第一人民医院2001—2005年收治的胆心综合征误诊为急性冠状动脉综合征13例患者介绍如下，并分析其误诊原因。 1临床资料 1．1一般资料 13例患者中，男9例，女4例，年龄37～72岁，平均年龄58岁。13例患者均有不同程度胸闷、心悸、心前区不适，表现为心前区疼痛5例，伴上腹部痛2例，阵发性心悸、气短5例，发作性胸骨后压榨样疼痛3例，4例胸痛时伴有低热、恶心、呕吐。     

女“糖友”更年期来得更早

据英国《每日邮报》报道,哥伦比亚卡塔赫纳大学的研究团队发现：相比普通女性,2型糖尿病女性患者更年期来得早的可能性会增加3倍。这些患者更年期来临的平均年龄为48．5岁,而非患者更年期来临的平均年龄为50．1岁。这就意味着,     

Management of chronic heart failure in the older population

Chronic heart failure （CHF） is the leading cause of hospitalization for those over the age of 65 and represents a significant clinical and economic burden. About half of hospital re-admissions are related to co-morbidities, polypharmacy and disabilities associated with CHF. Moreover, CHF also has an enormous cost in terms of poor prognosis with an average one year mortality of 33%–35%. While more than half of patients with CHF are over 75 years, most clinical trials have included younger patients with a mean age of 61 years. Inadequate data makes treatment decisions challenging for the providers. Older CHF patients are more often female, have less cardiovascular diseases and associated risk factors, but higher rates of non-cardiovascular conditions and diastolic dysfunction. The prevalence of CHF with reduced ejection fraction, ischemic heart disease, and its risk factors declines with age, whereas the prevalence of non-cardiac co-morbidities, such as chronic renal failure, dementia, anemia and malignancy increases with age. Diabetes and hypertension are among the strongest risk factors as predictors of CHF particularly among women with coronary heart disease. This review paper will focus on the specific consideration for CHF assessment in the older population. Management strategies will be reviewed, including non-pharmacologic, pharmacologic, quality care indicators, quality improvement in care transition and lastly, end-of-life issues. Palliative care should be an integral part of an interdiscipli-nary team approach for a comprehensive care plan over the whole disease trajectory. In addition, frailty contributes valuable prognostic in-sight incremental to existing risk models and assists clinicians in defining optimal care pathways for their patients.     

Catheter ablation of atrial fibrillation in the elderly

Background Atrial fibrillation （AF） catheter ablation has emerged as a promising treatment strategy for AF, but has not been widely adopted in the elderly population. The present study aimed to determine the safety and efficacy of AF catheter ablation in the elderly popula-tion. Methods and Results The study population consisted of 316 patients with paroxysmal AF who underwent left atrial ablation. Ninety-five patients were≥65 years （48 males, mean age 68.9 ± 3.0 years old） and 221 patients were〈65 years old （130 males, mean age 52.5 ± 10.4 years old）. After a mean follow-up period of 34.0 ± 15.1 months, 55 （57.9%） patients in the elderly group were free from ar-rhythmia recurrence compared with 149 （67.4%） patients in the younger group （P=0.169）. Procedural complications were uncommon in both study groups. In logistic regression analysis, left atrial diameter （P=0.003）, hypertension （P=0.001）, dyslipidemia （P=0.039）, and coronary artery disease （P=0.018） were independent predictors of AF recurrence in the elderly population. Conclusions Catheter ablation of AF is safe and effective in older patients. Invasive strategies should be considered as an alternative choice in symptomatic elderly patients with AF.